MYCN and neuroblastoma: For example, Kushner BH revealed two subgroups in MYCN‐amplified high‐risk patients, with one group having early disease progression and the other surviving for a long time,20 suggesting that there are other genetic aberrations attributed to the development and progression of high‐risk NB.